<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: us food and drug administration</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>US warns of cyber attacks on medical devices</title>
   	 <description>US authorities on Thursday warned makers of medical devices and hospital networks to step up efforts to guard against potential cyber attacks.</description>
	  <link>http://medicalxpress.com/news/2013-06-cyber-medical-devices.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 13 Jun 2013 14:56:12 EST</pubDate>
	 <guid isPermaLink="false">news290354163</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/amanusesarob.jpg" width="90" height="90" />
</item>
<item>
     <title>Researchers optimistic radioactive lead can beat cancer</title>
   	 <description>Atomic medicine has &quot;fantastic potential&quot; for fighting deadly, difficult to treat cancers, the head of French nuclear giant Areva's medical arm told AFP in an interview.</description>
	  <link>http://medicalxpress.com/news/2013-06-optimistic-radioactive-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 10 Jun 2013 05:10:01 EST</pubDate>
	 <guid isPermaLink="false">news290058489</guid>
	 
</item>
<item>
     <title>US experts review heart attack risk of diabetes drug</title>
   	 <description>GlaxoSmithKline's controversial diabetes drug Avandia, restricted in the US and banned in Europe over concerns it raises heart attack risk, is getting a second look this week by US medical experts.</description>
	  <link>http://medicalxpress.com/news/2013-06-experts-heart-diabetes-drug.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 05 Jun 2013 16:30:03 EST</pubDate>
	 <guid isPermaLink="false">news289667148</guid>
	 
</item>
<item>
     <title>France sees restrictions on e-cigarettes</title>
   	 <description>Health Minister Marisol Touraine on Friday said France would apply the same bans to electronic cigarettes as it does to tobacco but would not completely outlaw the popular smokeless product.</description>
	  <link>http://medicalxpress.com/news/2013-05-france-restrictions-e-cigarettes.html</link>
	 <category>Health</category>
	 <pubDate>Fri, 31 May 2013 12:30:01 EST</pubDate>
	 <guid isPermaLink="false">news289220082</guid>
	 
</item>
<item>
     <title>New sleeping pill poised to hit US markets</title>
   	 <description>An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.</description>
	  <link>http://medicalxpress.com/news/2013-05-pill-poised.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 21 May 2013 17:50:01 EST</pubDate>
	 <guid isPermaLink="false">news288376487</guid>
	 
</item>
<item>
     <title>Cancer research often falls short: study</title>
   	 <description>Cancer research tends to involve small studies focused on a single therapy, often falling short of scientific standards seen in other medical investigations, said a study released Monday.</description>
	  <link>http://medicalxpress.com/news/2013-04-cancer-falls-short.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 29 Apr 2013 19:14:46 EST</pubDate>
	 <guid isPermaLink="false">news286481679</guid>
	 
</item>
<item>
     <title>Doctors say cancer drug costs are too high</title>
   	 <description>More than 100 doctors from around the world have signed a letter decrying the high cost of cancer drugs which reach $100,000 per year or more, and calling for pharmaceutical companies to ease prices.</description>
	  <link>http://medicalxpress.com/news/2013-04-doctors-cancer-drug-high.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 26 Apr 2013 13:35:55 EST</pubDate>
	 <guid isPermaLink="false">news286202148</guid>
	 
</item>
<item>
     <title>Another day, another anti-obesity campaign, but will this one work?</title>
   	 <description>Merely two months into the new year and we have already seen a plethora of local and international efforts aimed at curbing what appears to be the inexorable rise of obesity. Some of these initiatives are starting to reset the agenda for the community discussion around obesity.</description>
	  <link>http://medicalxpress.com/news/2013-03-day-anti-obesity-campaign.html</link>
	 <category>Overweight and Obesity</category>
	 <pubDate>Fri, 01 Mar 2013 11:00:01 EST</pubDate>
	 <guid isPermaLink="false">news281356753</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/anotherdayan.jpg" width="90" height="90" />
</item>
<item>
     <title>Bionic eye gives hope to the blind</title>
   	 <description>After years of research, the first bionic eye has seen the light of day in the United States, giving hope to the blind around the world.</description>
	  <link>http://medicalxpress.com/news/2013-02-bionic-eye.html</link>
	 <category>Ophthalmology</category>
	 <pubDate>Tue, 05 Feb 2013 18:21:02 EST</pubDate>
	 <guid isPermaLink="false">news279310852</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/amanreceives.jpg" width="90" height="90" />
</item>
<item>
     <title>Study reveals long-term effects on child IQ of epilepsy drug valproate during pregnancy</title>
   	 <description>Research published today in the Lancet Neurology shows that taking the antiepileptic drug valproate during pregnancy affects the IQ of children up to the age of six.</description>
	  <link>http://medicalxpress.com/news/2013-01-reveals-long-term-effects-child-iq.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 22 Jan 2013 18:30:02 EST</pubDate>
	 <guid isPermaLink="false">news278098291</guid>
	 
</item>
<item>
     <title>Sleeping pills owe half their benefits to placebo effect, study finds</title>
   	 <description>Half of the benefit of taking sleeping pills comes from the placebo effect, according to a major new study published in the British Medical Journal.</description>
	  <link>http://medicalxpress.com/news/2012-12-pills-benefits-placebo-effect.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 18 Dec 2012 16:01:03 EST</pubDate>
	 <guid isPermaLink="false">news275068840</guid>
	 
</item>
<item>
     <title>FDA investigates possible energy drink-linked deaths</title>
   	 <description>The US Food and Drug Administration is investigating 13 deaths that may be linked to consumption of an energy drink called 5-hour Energy, an FDA spokeswoman said Thursday.</description>
	  <link>http://medicalxpress.com/news/2012-11-fda-energy-drink-linked-deaths.html</link>
	 <category>Health</category>
	 <pubDate>Thu, 15 Nov 2012 17:36:28 EST</pubDate>
	 <guid isPermaLink="false">news272223368</guid>
	 
</item>
<item>
     <title>Feinstein announces submission of new drug application for diagnosing parkinsonian syndromes</title>
   	 <description>The Feinstein Institute for Medical Research announced today the submission of a New Drug Application to the US Food and Drug Administration (FDA) for the Fluorodopa F 18 positron emission tomography (PET) scan used to diagnose parkinsonian syndromes. Earlier this year, the Feinstein Institute received FDA approval under an Expanded Access Investigational New Drug (IND) program, permitting the Feinstein Institute to receive reimbursement for the use of the diagnostic tool in clinical research studies. This was the first time the FDA approved payment for Fluorodopa F 18 PET studies in parkinsonian syndromes.</description>
	  <link>http://medicalxpress.com/news/2012-11-feinstein-submission-drug-application-parkinsonian.html</link>
	 <category>Parkinson's &amp; Movement disorders</category>
	 <pubDate>Wed, 14 Nov 2012 12:57:34 EST</pubDate>
	 <guid isPermaLink="false">news272120187</guid>
	 
</item>
<item>
     <title>Product regulatory systems in low-and middle-income countries must be strengthened</title>
   	 <description>When regulatory systems for medical products in low-and middle-income countries work, people live but when such systems fail, people die, according to experts from the US Food and Drug Administration (FDA) writing in this week's PLOS Medicine.</description>
	  <link>http://medicalxpress.com/news/2012-10-product-regulatory-low-and-middle-income-countries.html</link>
	 <category>Health</category>
	 <pubDate>Tue, 23 Oct 2012 17:10:11 EST</pubDate>
	 <guid isPermaLink="false">news270225325</guid>
	 
</item>
<item>
     <title>FDA recommends approval for Second Sight's Argus II retinal prosthesis system in the US</title>
   	 <description>On Friday September 28, a U.S. Food and Drug Administration (FDA) Ophthalmic Devices Advisory Panel unanimously voted 19-0 that the probable benefit of the Argus II Retinal Prosthesis System outweighs the risks to health, an important step toward the FDA market approval of this product manufactured by Second Sight Medical Products, Inc. In making this determination, the panel spent ten hours carefully reviewing and discussing data submitted from the international clinical trial of this innovative retinal implant that, for the first time ever, partially restores vision to patients who are blind due to Retinitis Pigmentosa (RP).</description>
	  <link>http://medicalxpress.com/news/2012-10-fda-sight-ii-retinal-prosthesis.html</link>
	 <category>Ophthalmology</category>
	 <pubDate>Wed, 03 Oct 2012 04:03:12 EST</pubDate>
	 <guid isPermaLink="false">news268455784</guid>
	 
</item>
<item>
     <title>S. Korea deploys 'floating toilets' after US warning</title>
   	 <description> South Korea will spend over half a million dollars on building floating toilets around shellfish farms to boost sanitary controls, officials said Wednesday, after US health authorities warned of contamination.</description>
	  <link>http://medicalxpress.com/news/2012-09-korea-deploys-toilets.html</link>
	 <category>Health</category>
	 <pubDate>Wed, 12 Sep 2012 06:19:21 EST</pubDate>
	 <guid isPermaLink="false">news266649550</guid>
	 
</item>
<item>
     <title>Women 40% less likely to die after TAVI than men</title>
   	 <description>Women with severe aortic stenosis are 40% less likely to die after transcatheter aortic valve implantation (TAVI) than men, reveals the latest data from the largest study to date of gender differences in outcomes after TAVI. The findings were presented at ESC Congress 2012 by Professor Karin Humphries from St. Paul's Hospital.</description>
	  <link>http://medicalxpress.com/news/2012-08-women-die-tavi-men.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 28 Aug 2012 11:30:01 EST</pubDate>
	 <guid isPermaLink="false">news265370859</guid>
	 
</item>
<item>
     <title>US finds lead poisoning from Ayurvedic medicines</title>
   	 <description> US health researchers said Thursday that they have documented lead poisoning risks among pregnant women who took Ayurvedic medicine and issued a new warning on the safety of traditional pills.</description>
	  <link>http://medicalxpress.com/news/2012-08-poisoning-ayurvedic-medicines.html</link>
	 <category>Health</category>
	 <pubDate>Thu, 23 Aug 2012 13:20:01 EST</pubDate>
	 <guid isPermaLink="false">news264945379</guid>
	 
</item>
<item>
     <title>Cardiovascular benefits of taking statins outweigh diabetes risk</title>
   	 <description>The benefits of taking statins to reduce the risk of cardiovascular disease outweigh the increased risk of developing diabetes experienced by some patients who take these cholesterol-lowering drugs, according to an Article published Online First in The Lancet.</description>
	  <link>http://medicalxpress.com/news/2012-08-cardiovascular-benefits-statins-outweigh-diabetes.html</link>
	 <category>Diabetes</category>
	 <pubDate>Thu, 09 Aug 2012 18:30:01 EST</pubDate>
	 <guid isPermaLink="false">news263738102</guid>
	 
</item>
<item>
     <title>Concerns over minimally invasive heart valve surgery</title>
   	 <description>A new type of heart valve surgery known as transcatheter aortic valve implantation &quot;cannot be justified on medical or cost effectiveness grounds&quot; warn experts in a paper published in BMJ today.</description>
	  <link>http://medicalxpress.com/news/2012-07-minimally-invasive-heart-valve-surgery.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 31 Jul 2012 18:30:01 EST</pubDate>
	 <guid isPermaLink="false">news262968994</guid>
	 
</item>
<item>
     <title>Package inserts overstate diagnostic TB tests' accuracy</title>
   	 <description>Clinicians and laboratory professionals often rely on manufacturers' package inserts to assess the accuracy of diagnostic medical tests. However, package inserts frequently greatly overstate such tests' accuracy, according to a case study of package inserts for tuberculosis (TB), which is published in the July 2012 Journal of Clinical Microbiology.</description>
	  <link>http://medicalxpress.com/news/2012-07-package-inserts-overstate-diagnostic-tb.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 17 Jul 2012 16:48:52 EST</pubDate>
	 <guid isPermaLink="false">news261762517</guid>
	 
</item>
<item>
     <title>UNAIDS welcomes US approval of drug to stop HIV</title>
   	 <description> The UN agency tasked with fighting AIDS on Tuesday welcomed the decision by the United States to allow the use of an HIV prevention pill for the first time.</description>
	  <link>http://medicalxpress.com/news/2012-07-unaids-drug-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 17 Jul 2012 06:38:40 EST</pubDate>
	 <guid isPermaLink="false">news261725914</guid>
	 
</item>
<item>
     <title>US approves first pill to help prevent HIV</title>
   	 <description>(AP) &amp;#151; The Food and Drug Administration on Monday approved the first drug shown to reduce the risk of HIV infection, the latest milestone in the 30-year battle against the virus that causes AIDS.</description>
	  <link>http://medicalxpress.com/news/2012-07-truvada-pill-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 16 Jul 2012 13:08:13 EST</pubDate>
	 <guid isPermaLink="false">news261662862</guid>
	 
</item>
<item>
     <title>Hong Kong's first anti-cancer drug granted with US FDA IND</title>
   	 <description>(Medical Xpress) -- The discovery of a new drug for liver cancer by researchers of The Hong Kong Polytechnic University (PolyU) and local medical practitioner has born fruit. After completing clinical trials locally, the new drug known as &quot;BCT-100&quot; has become Hong Kong's first &quot;Investigational New Drug&quot; (IND) granted by the US Food and Drug Administration (FDA).</description>
	  <link>http://medicalxpress.com/news/2012-06-hong-kong-anti-cancer-drug-granted.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 29 Jun 2012 07:13:47 EST</pubDate>
	 <guid isPermaLink="false">news260172801</guid>
	 
</item>
<item>
     <title>Roche probed over faulty drug-safety reporting</title>
   	 <description> Swiss pharmaceutical giant Roche is under investigation over a failure to properly report adverse drug side-effects, the European Medicines Agency (EMA) said on Thursday.</description>
	  <link>http://medicalxpress.com/news/2012-06-roche-probed-faulty-drug-safety.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 21 Jun 2012 17:02:17 EST</pubDate>
	 <guid isPermaLink="false">news259516928</guid>
	 
</item>
<item>
     <title>FDA panel urges approval for Pfizer arthritis drug</title>
   	 <description> An advisory committee to the US Food and Drug Administration on Wednesday urged US regulators to approve a new treatment for rheumatoid arthritis made by the pharmaceutical giant Pfizer.</description>
	  <link>http://medicalxpress.com/news/2012-05-fda-panel-urges-pfizer-arthritis.html</link>
	 <category>Arthritis &amp; Rheumatism</category>
	 <pubDate>Wed, 09 May 2012 18:08:51 EST</pubDate>
	 <guid isPermaLink="false">news255805725</guid>
	 
</item>
<item>
     <title>US watchdog warns on fitness stimulant</title>
   	 <description> The US Food and Drug Administration on Friday questioned the safety of DMAA, a stimulant used in dietary supplements, alleging that marketers were illegally selling the chemical.</description>
	  <link>http://medicalxpress.com/news/2012-04-watchdog.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 27 Apr 2012 18:10:14 EST</pubDate>
	 <guid isPermaLink="false">news254769007</guid>
	 
</item>
<item>
     <title>Supreme Court ruling supports generic drug makers</title>
   	 <description> The US Supreme Court ruled Tuesday that generic drug makers can challenge big-name pharmaceutical firms in court to stop them from broadening the scope of their patent descriptions.</description>
	  <link>http://medicalxpress.com/news/2012-04-supreme-court-drug-makers.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 18 Apr 2012 00:33:23 EST</pubDate>
	 <guid isPermaLink="false">news253927980</guid>
	 
</item>
<item>
     <title>Sushi 'tuna scrape' blamed for US salmonella outbreak</title>
   	 <description> A ground fish product known as &quot;tuna scrape,&quot; imported to the United States from India, was blamed Monday for a salmonella outbreak that has sickened 116 people, US health authorities said.</description>
	  <link>http://medicalxpress.com/news/2012-04-sushi-tuna-blamed-salmonella-outbreak.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 16 Apr 2012 18:04:04 EST</pubDate>
	 <guid isPermaLink="false">news253818237</guid>
	 
</item>
<item>
     <title>FDA to decide on Qnexa obesity drug in July</title>
   	 <description> US regulators will decide in July whether to approve Qnexa, the first obesity drug in more than a decade, extending the initial deadline by three months, the California-based drug-maker VIVUS said.</description>
	  <link>http://medicalxpress.com/news/2012-04-obesity-drug-july.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 10 Apr 2012 12:15:20 EST</pubDate>
	 <guid isPermaLink="false">news253278870</guid>
	 
</item>


</channel>
</rss>
